Speakers

Artem Andrianov, Ph.D., MBA

Managing Director

Cyntegrity

Mary Arnould

Director

Astellas Pharma

Christopher Biddle

Associate Director, Risk Management and Central Monitoring

Janssen Research

Stephanie Clark

Director, Risk Management - Central Monitoring

The Janssen Pharmaceutical Companies of Johnson & Johnson

John (Jay) Daly

Clinical Study Risk Management Lead, Clinical Data Operations, Technology and Standards

UCB Biopharma

Gayle Hamilton

Lead RBM Project Advisor

IQVIA

Lisa Henderson

Group Content Director, Applied Clinical Trials and Pharmaceutical Executive

MJH Associates Inc.

Esther Huffman O'Keefe

Associate Director, Monitoring, Global Clinical Operations

Regeneron

Beenu Kapoor

VP, IT, Trial Management

IQVIA Technologies

Andy Lawton

Director

Risk-Based Approach Ltd

Kristin Mauri

Solutions Services Director

Remarque Systems

Ann Meeker O'Connell

Vice President, Integrated QMS/OMS

Vertex Pharmaceuticals

Jamie O'Neill

Senior Manager, Central Monitoring Operations

Covance

Rosanne Petros, PMP

Associate Director, Clinical Research

Merck Research Laboratories

Johann Proeve, Ph.D.

Chief Scientific Officer

Cyntegrity

Craig Reist, Ph.D.

VP & Chief Scientific Officer

2M Clinical

MaryAnne Rizk, Ph.D.

Senior Vice President, Digital R&D Strategy

IQVIA Technologies

Kristin Stallcup

Senior Director, Xcellerate Customer Success

Covance

Michael Walega

Head of Centralized Monitoring

Bristol Myers Squibb

Nico Wegener, Ph.D.

Senior Clinical Project Manager

Merz Pharmaceuticals

Steve Whittaker

Senior Consultant

The Avoca Group

Marion Wolfs

Head, Senior Director Risk Management & Central Monitoring

The Janssen Pharmaceutical Companies of Johnson & Johnson

Steve Young

Chief Scientific Officer

CluePoints